Combined incubation of platelets and endothelial cells with glycated albumin: Altered thrombogenic and inflammatory responses. 
Diabetes mellitus is a salient risk factor for the development of cardiovascular diseases (CVDs).  Part of this risk is associated with the presence of advanced glycation end products (AGEs), which have been shown to up-regulate platelet or endothelial cell inflammatory and thrombogenic responses that are associated with CVDs.  However, platelets perform mechanisms that alter endothelial cell inflammatory and thrombogenic responses, and endothelial cells perform similar mechanisms on platelets.  Thus, our goal was to evaluate platelet and endothelial cell inflammatory and thrombogenic reactions that AGEs elicit during concurrent exposure.  Endothelial cells were incubated with AGEs for 5 days, after which platelets were added.  A time course for CVD inflammatory and thrombogenic responses was quantified as a function of extent of glycation.  In general, the presence of platelets reduced AGE-induced endothelial cell responses associated with CVD progression and the presence of endothelial cells reduced platelet adhesion and activation responses, as compared with individual exposures.  In general, the presence of irreversibly glycated albumin promoted CVD development to a greater extent than reversibly glycated albumin.  This suggests that under diabetic conditions, platelets and endothelial cells can negatively feedback on each other, likely via enhanced adhesion, to elicit a reduced response associated with CVD progression.